NEW YORK (GenomeWeb News) – Protea Biosciences said today that it has entered into a collaborative research agreement with Virginia Commonwealth University and its Center for Molecular Imaging focused on improved molecular imaging techniques for the study of cancer, Alzheimer's, and other diseases.

Under the collaboration, the parties will work to combine Protea's ex vivo molecular imaging mass spectrometry technology, Laser Ablation Electrospray Ionization, or LAESI, with VCU's in vivo molecular PET, SPECT and MRI/MRS imaging capabilities.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.